| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/11/2002 | CN1368053A Nano medicine 'Zhenshiming' and its preparing process |
| 09/11/2002 | CN1090507C Novel pharmaceutical application of nonimmunogenproteinic material and composition |
| 09/11/2002 | CN1090505C 多功能酶 Multifunctional enzyme |
| 09/11/2002 | CN1090484C Eye drops for curing electric ophthalimia |
| 09/11/2002 | CN1090476C Sterile ophthalmological gel propn. applicable in drops and process for producing it |
| 09/10/2002 | US6448283 Fused pyrrolocarbazoles; hearing loss and loss of the sense of balance |
| 09/10/2002 | US6448277 VEGF receptor tyrosine kinase inhibitors |
| 09/10/2002 | US6448274 Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor |
| 09/10/2002 | US6448272 Myt1 kinase inhibitors |
| 09/10/2002 | US6448254 Substituted amides, their production and their use |
| 09/10/2002 | US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 09/10/2002 | US6448036 ribB |
| 09/10/2002 | US6448011 Isolated nucleic acid, vectors, transformed mammalian cells and non-human transgenic animals that encode and express normal or mutant adrenergic receptor genes. |
| 09/10/2002 | CA2200481C Method and means for prevention and treatment of secondary cataract |
| 09/06/2002 | WO2002068461A2 Heterocarpine, a human ghrh-binding protein |
| 09/06/2002 | WO2002068406A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 09/06/2002 | WO2002068383A2 Thiol-modified hyaluronan |
| 09/06/2002 | WO2002068381A2 Aryl-n-cyanoguanidines and methods related thereto |
| 09/06/2002 | WO2002067977A1 Eye drops |
| 09/06/2002 | WO2002067971A2 Use of endostatin in the treatment of ocular neovascularization |
| 09/06/2002 | WO2002067970A1 TRYPTOPHANYL-tRNA SYNTHETASE DERIVED POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 09/06/2002 | WO2002067950A1 Vascular regeneration promoters |
| 09/06/2002 | WO2002067917A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/06/2002 | WO2002067851A2 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | WO2002067831A1 Composition for freshening nostrils and sinus cavities |
| 09/06/2002 | WO2002067688A1 Noninvasive measurements of chemical substances |
| 09/06/2002 | WO2002043648A8 Compounds active at the glucocorticoid receptor ii |
| 09/06/2002 | WO2002041882A3 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 09/06/2002 | WO2002040517A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002040062A3 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 09/06/2002 | WO2002040037A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002038563A3 Condensed pyrazindione derivatives as pde inhibitors |
| 09/06/2002 | WO2002036771A3 Imaging, diagnosis and treatment of disease |
| 09/06/2002 | WO2002012250A3 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 09/06/2002 | WO2001098334A3 Streptococcus antigens |
| 09/06/2002 | WO2001094612A3 Method for identifying medically valuable active substances |
| 09/06/2002 | CA2617312A1 Noninvasive measurement of chemical substances |
| 09/06/2002 | CA2617004A1 Noninvasive measurements of chemical substances |
| 09/06/2002 | CA2475454A1 Aryl-n-cyanoguanidines and methods related thereto |
| 09/06/2002 | CA2439100A1 Eye drop |
| 09/06/2002 | CA2438784A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/06/2002 | CA2438630A1 Composition for freshening nostrils and sinus cavities |
| 09/06/2002 | CA2438273A1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis |
| 09/06/2002 | CA2437516A1 Heterocarpine, a human ghrh-binding protein |
| 09/06/2002 | CA2437417A1 Thiol-modified hyaluronan |
| 09/06/2002 | CA2433425A1 Method for treating fibrotic diseases or other indications iiic |
| 09/05/2002 | US20020123520 3',5'-cyclic nucleotide phosphodiesterases (PDEs); disease related to eosinophils, such as asthma, chronic bronchitis, and chronic obstructuive pulmonary disease |
| 09/05/2002 | US20020123504 In an inert carrier; instant release; treating allergic rhinitis and other histamine-induced disorders |
| 09/05/2002 | US20020123488 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine |
| 09/05/2002 | US20020123482 Artificial tear composition containing a combination of three demulcents |
| 09/05/2002 | US20020123141 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 09/05/2002 | US20020123119 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides and for treatment and prevention of infections |
| 09/05/2002 | US20020123047 dexB |
| 09/05/2002 | US20020122833 Herbal compositions for treating immunological disorders |
| 09/05/2002 | US20020122793 Heparinase III and uses thereof |
| 09/05/2002 | DE10109861A1 Neuartige seitenkettenhalogenierte Aminodicarbonsäurederivate Novel side-chain halogenated Aminodicarbonsäurederivate |
| 09/05/2002 | DE10109859A1 Neuartige Aminodicarbonsäurederivate Novel Aminodicarbonsäurederivate |
| 09/04/2002 | EP1236720A1 Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| 09/04/2002 | EP1236471A2 Angiostatic steroids |
| 09/04/2002 | EP1236470A2 Angiostatic steroids |
| 09/04/2002 | EP1236469A2 Angiostatic steroids |
| 09/04/2002 | EP1235934A2 Screening method for candidate drugs |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235851A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 09/04/2002 | EP1235849A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235827A2 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 09/04/2002 | EP1235825A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 09/04/2002 | EP1235824A1 Vitamin d analogues |
| 09/04/2002 | EP1235814A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 09/04/2002 | EP1235812A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 09/04/2002 | EP1235803A1 Urea compounds having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235802A1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235793A2 Vla-4 integrin antagonists |
| 09/04/2002 | EP1235777A2 Vitamin d analogues |
| 09/04/2002 | EP1235594A2 Inhibition of secretion from non-neuronal cells |
| 09/04/2002 | EP1004307B1 Ophthalmic composition |
| 09/04/2002 | EP0932389B1 Ophthalmic compositions containing a carbonic anhydrase inhibitor and xanthan gum |
| 09/04/2002 | EP0809636B1 Substituted isoxazoles for the treatment of inflammation |
| 09/04/2002 | CN1367793A Neuromedin B and somatostatin receptor agonists |
| 09/04/2002 | CN1367791A Novel angiogenesis inhibitor |
| 09/04/2002 | CN1367790A Moraxella cattarrhalis BASB114 polypeptide antigens and uses thereof |
| 09/04/2002 | CN1367787A Water soluble SDZ-RAD esters |
| 09/04/2002 | CN1367775A Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| 09/04/2002 | CN1367698A Administration of non-oral androgenic steroids to women |
| 09/04/2002 | CN1367695A Phthalazine derivatives for treating inflammatory diseases |
| 09/04/2002 | CN1367693A Pharmaceutical compositions containing poly(ADP-ribose) glycohydrolase inhibitors and method of using the same |
| 09/04/2002 | CN1367018A Compound preparation of staphylococcolysis enzyme and its preparation method and application |
| 09/04/2002 | CN1366992A Medicine for external application for curing scald and burn, its production method and application |
| 09/04/2002 | CN1366962A Nano Erding preparation medicine and preparation method |
| 09/03/2002 | US6444829 (2s,4r)-4-mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid n'-isobutyl-n'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 09/03/2002 | US6444791 Therapy for vision defects; administering macroglobulins |
| 09/03/2002 | US6444702 Central nervous system disorders |
| 09/03/2002 | US6444686 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 09/03/2002 | US6444677 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 09/03/2002 | US6444639 Human chorionic gonadotrophin (hcg) used to treat or prevent tumors, multiple sclerosis, inflammation or angiogenesis-dependent diseases |
| 09/03/2002 | US6444431 Angiostatin receptor |
| 09/03/2002 | CA2225626C Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 09/03/2002 | CA2178085C Glutaramide derivatives |
| 09/03/2002 | CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors |